Streetbeat News

Analyst Ratings

AXSM

Piper Sandler analyst David Amsellem has maintained an Overweight rating on Axsome Therapeutics (NASDAQ:AXSM) and increased the price target from $90 to $113, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:42 pm

CVNA

JMP Securities analyst Nicholas Jones has reiterated a 'Market Outperform' rating on Carvana (NYSE:CVNA) and maintained a price target of $60.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:41 pm

BPMC

JMP Securities analyst Reni Benjamin has reiterated a 'Market Outperform' rating on Blueprint Medicines (NASDAQ:BPMC) and maintained a price target of $114.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:39 pm

ACVA

JMP Securities analyst Nicholas Jones has maintained a Market Outperform rating on ACV Auctions (NASDAQ:ACVA) but reduced the price target from $20 to $19.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:38 pm

UNH

Stephens & Co. analyst Scott Fidel has maintained an Overweight rating on UnitedHealth Group (NYSE:UNH) but reduced the price target from $615 to $605.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:28 pm

EHC

Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Encompass Health (NYSE:EHC) and maintained a price target of $85.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:25 pm

ARWR

RBC Capital analyst Luca Issi has reiterated an Outperform rating on Arrowhead Pharma (NASDAQ:ARWR) and maintained a $50 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:17 pm

BA

Boeing Co (NYSE:BA) stock is trading lower due to additional quality inspections required for its 737 MAX jets after a cabin panel incident on an Alaska Airlines flight. Boeing plans to oversee work at Spirit AeroSystems and conduct checks at 50 other points. The FAA extended grounding orders for Boeing Max 9s, and United and Alaska Airlines canceled flights. Additionally, Wells Fargo downgraded Boeing from Overweight to Equal-Weight and lowered the price target from $280 to $225.

Portfolio Pulse from Adam Eckert

January 16, 2024 | 2:15 pm

BSX

RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Boston Scientific (NYSE:BSX) and maintained a price target of $67.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:15 pm

BA

Boeing's stock (BA) trades lower following a downgrade by Wells Fargo from Overweight to Equal-Weight and a reduction in the price target from $280 to $225.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:15 pm